Today@Dal
» Go to news mainResearch study for healthy men ages 18‑44
Posted by Clinical Trials Research Center on
August 20, 2013
in
General Announcements
RSV (respiratory syncitial virus) CAN cause serious lung infections in infants, young children and the elderly The Canadian Center for Vaccinology at the IWK is studying a vaccine that may provide protection against RSV.
If you are a healthy man between the ages of 18 and 44 and are interested in taking part in this important study, please contact Cathy at 470-7015.
If eligible to take part, you will be reimbursed for travel and parking.
For more information about the study and the Canadian Center for Vaccinology, please visit our website.
Recent News
- Ergonomic assessments available
- First edition of the EH&S newsletter out now
- Job postings
- Seeking youth 9‑15 for clinical trial of CMV vaccine
- In Memoriam: Dr. Philip Welch
- Guidance for use of generative A.I. tools in research
- 5th annual Employee Wellness Day
- Job postings